Chelmsford Psychophamacology is categorized under Psychiatric Treatment Facilities in Chelmsford, MA .
Chelmsford Psychophamacology was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Psychiatric Treatment Facilities business, which does work in the B2C market, and is classified as a Psychiatric Treatment Facilities, under code number 6222100 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 6 Courthouse Lane Unit 12, Chelmsford, Massachusetts MA 01824 or by phoning (978) 251-3595. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Chelmsford Psychophamacology |
Address: | 6 Courthouse Lane Unit 12, Chelmsford, Massachusetts 01824 |
Phone Number: | (978) 251-3595 |
Website Address: | chelmsfordpsychopharm.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Psychiatric Treatment Facilities |
SIC Code: | 8063 |
NAICS Code: | 6222100 |
Share This Business: |
Chelmsford Psychophamacology was started in 0 to provide professional Psychiatric Treatment Facilities under the SIC code 8063 and NAICS code 6222100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact for inquiries that concern Chelmsford Psychophamacology by calling the company number (978) 251-3595, as your correspondence is most welcome. Additionally, the physical location of the single location of Chelmsford Psychophamacology can be found at the coordinates 42.624072,-71.359833 as well as the street address 6 Courthouse Lane Unit 12 in Chelmsford, Massachusetts 01824.
For its online presence, you may visit Chelmsford Psychophamacology’s website at chelmsfordpsychopharm.com and engage with its social media outlets through on Twitter and on Facebook.